Marginal zone B-cell lymphoma: A retrospective immunophenotypic analysis

Cytometry Part B - Clinical Cytometry

Volumn 74, Issue 5, 2008, Pages 282-286

  Kost, Christine B ^a   Holden, Jeannine T ^a   Mann, Karen P ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Flow cytometry; Immunophenotype; MALT lymphoma; Marginal zone lymphoma; Nodal marginal zone lymphoma; Splenic marginal zone lymphoma

Indexed keywords

B LYMPHOCYTE ANTIGEN; CD19 ANTIGEN; CD20 ANTIGEN; CD38 ANTIGEN; CD45 ANTIGEN; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; GLYCOPROTEIN P 15095;

ANTIGEN EXPRESSION; ARTICLE; B CELL LYMPHOMA; CANCER GRADING; CLINICAL ARTICLE; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; FLOW CYTOMETRY; FLUORESCENCE ACTIVATED CELL SORTING; FLUORESCENCE ANALYSIS; FOLLICULAR LYMPHOMA; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; PRIORITY JOURNAL; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE;

ANTIBODIES, NEOPLASM; ANTIGENS, NEOPLASM; FLUORESCENCE; HUMANS; IMMUNOPHENOTYPING; LYMPHOMA, B-CELL, MARGINAL ZONE; LYMPHOMA, FOLLICULAR; RETROSPECTIVE STUDIES;

EID: 51749104611     PISSN: 15524949     EISSN: 15524957     Source Type: Journal    
DOI: 10.1002/cyto.b.20426     Document Type: Article

References (21)

1. Harris NL, Jaffe ES, Diebold J, Flandrin G, Müller-Hermelink HK, Vardiman J, Lister TA, Bloomfield CD, editors. The World Health Organization classification of hematological malignancies report of the Clinical Advisory Committee Meeting, Airlie House, 1997. Virginia: WHO; 2000. Vol. 13, pp 193-207.
2. Hollema H, Visser L, Poppema S. Small lymphocytic lymphomas with predominant splenomegaly: A comparison of immunophenotypes with cases of predominant lymphadenopathy. Mod Pathol 1991;4:712-717.
3. Isaacson PG, Du MQ. MALT lymphoma: From morphology to molecules. Nat Rev Cancer 2004;4:644-653. [Review] [115 refs].
4. Nathwani BN, Anderson JR, Armitage JO, Cavalh I, Diebold J, Drachenberg MR, Harris NL, MacLennan KA, Müller-Hermelink HK, Ullrich FA, Weisenburger DD. Marginal zone B-cell lymphoma: A clinical comparison of nodal and mucosa-associated lymphoid tissue types. Non-Hodgkin's lymphoma classification project. J Clin Oncol 1999;17:2486-2492.
5. Ott MM, Rosenwald A, Katzenberger T, Dreyling M, Krumdiek AK, Kalla J, Greiner A, Ott G, Müller-Hermelink HK. Marginal zone B-cell lymphomas (MZBL) arising at different sites represent different biological entities. Genes Chromosomes Cancer 2000;28:380-386.
6. Schmid C, Kirkham N, Diss T, Isaacson PG. Splenic marginal zone cell lymphoma. Am J Surg Pathol 1992;16:455-466.
7. Thieblemont C, Felman P, Callet-Bauchu E, Traverse-Glehen A, Salles G, Berger F, Coiffier B. Splenic marginal-zone lymphoma: A distinct clinical and pathological entity. Lancet Oncol 2003;4:95-103. [Review] [74 refs].
8. D'Arena G, Keating MJ, Carotenuto M. Chronic lymphoproliferative disorders: An integrated point of view for the differential diagnosis. Leuk Lymphoma 2000;36:225-237. [Review] [84 refs].
9. D'Arena G, Musto P, Cascavilla N, Dell'Olio M, Di Renzo N, Carotenuto M. Quantitative flow cytometry for the differential diagnosis of leukemic B-cell chronic lymphoproliferative disorders. Am J Hemat 2000;64:275-281.
10. Rothe G, Schmitz G. Consensus protocol for the flow cytometric immunophenotyping of hematopoietic malignancies. Working Group on Flow Cytometry and Image Analysis [see comment]. Leukemia 1996;10:877-895.
11. Arcaini L, Paulli M, Boveri E, Magrini U, Lazzarino M. Marginal zone-related neoplasms of splenic and nodal origin. Haematologica 2003;88:80-93. [Review] [95 refs].
12. Berger F, Felman P, Thieblemont C, Pradier T, Baseggio L, Bryon PA, Salles G, Callet-Bauchu E, Coiffier B. Non-MALT marginal zone B-cell lymphomas: A description of clinical presentation and outcome in 124 patients. Blood 2000;95:1950-1956.
13. Maes B, De Wolf-Peeters C. Marginal zone cell lymphoma-An update on recent advances. Histopathology 2002;40:117-126. [Review] [116 refs].
14. Jaffe ES, Harris NL, Stein H, Vardiman JW. Splenic marginal zone lymphoma. In: Isaacson PG, Piris MA, Catovsky D, Swerdlow S, Montserrat E, Berger F, Muller-Hermelink HK, Nathwani B, Harris NL, editors. World Health Organization Classification of Tumours: Pathology and Genetics Tumours of Haematopoietic and Lymphoid Tissues. Lyon: WHO; 2001. pp 135-137.
15. Jaffe ES, Harris NL, Stein H, Vardiman JW. Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma). In: Isaacson PG, Müller-Hermelink HK, Piris MA, Berger F, Nathwani BN, Swerdlow SH, Harris NL, editors. World Health Organization Classification of Tumours: Pathology and Genetics of Haematopoietic and Lymphoid Tissues. Lyons: WHO; 2001. pp 157-160.
16. Ginaldi L, De Martinis M, Matutes E, Farahat N, Morilla R, Catovsky D. Levels of expression of CD19 and CD20 in chronic B cell leukaemias. J Clin Pathol 1998;51:364-369.
17. Morse HC III, Kearney JF, Isaacson PG, Carroll M, Fredrickson TN, Jaffe ES. Cells of the marginal zone-Origins, function and neoplasia. Leuk Res 2001;25:169-178.
18. Matutes E, Morilla R, Owusu-Ankomah K, Houlihan A, Catovsky D. The immunophenotype of splenic lymphoma with villous lymphocytes and its relevance to the differential diagnosis with other B-cell disorders. Blood 1994;83:1559-1562.
19. Ocio EM, Hernandez JM, Mateo G, Sanchez ML, Gonzalez B, Vidriales B, Gutierrez NC, Orfao A, San Miguel JF. Immunophenotypic and cytogenetic comparison of Waldenstrom's macroglobulinemia with splenic marginal zone lymphoma. Clin Lymphoma 2005; 5:241-245.
20. Sanchez ML, Almeida J, Vidriales B, Lopez-Berges MC, Garcia-Marcos MA, Moro MJ, Corrales A, Calmuntia MJ, San Miguel JF, Orfao A. Incidence of phenotypic aberrations in a series of 467 patients with B chronic lymphoproliferative disorders: Basis for the design of specific four-color staining to be used for minimal residual disease investigation. Leukemia 2002;16:1460-1469.
21. Yang W, Agrawal N, Patel J, Edinger A, Osei E, Thur D, Powers J, Meyerson H. Diminished expression of CD19 in B-cell lymphomas. Cytometry Part B 2005;63B:28-35.